Table.
Table. Cytotoxic activity (IC50, µM) of the final compounds (1–16) against various cancer cell lines and their selectivity index values.
| |||||||
|---|---|---|---|---|---|---|---|
| Com | R | A | SH-SY5Y | PANC-1 | MDA-MB-231 | MCF-10a | SI* |
| 1 | hydrogen | phenyl | 92.2 ± 1.5 | 86.7 ± 1.4 | 140.4 ± 1.1 | 78.2 ± 1.6 | 0 |
| 2 | chloro | phenyl | 29.0 ± 1.5 | 86.6 ± 1.6 | 99.7 ± 1.1 | 232.9 ± 2.1 | 2.3 |
| 3 | methoxy | phenyl | 57.4 ± 1.6 | 103.7 ± 1.6 | 110.6 ± 1.2 | 98.9 ± 1.2 | 0 |
| 4 | methyl | phenyl | 75.9 ± 1.6 | 86.6 ± 1.4 | 89.7 ± 1.5 | 132.2 ± 1.7 | 1.5 |
| 5 | hydrogen | morpholine | 118.4 ± 1.8 | 24.2 ± 2.1 | 102.9 ± 1.7 | 89.6 ± 1.5 | 0 |
| 6 | chloro | morpholine | 80.6 ± 1.9 | 8.8 ± 2.1 | 136.5 ± 1.5 | 70.7 ± 1.8 | 0 |
| 7 | methoxy | morpholine | 134.0 ± 1.7 | 1.2 ± 1.8 | 77.01 ± 1.7 | 118.5 ± 1.2 | 1.5 |
| 8 | methyl | morpholine | 79.3 ± 1.6 | 120.3 ± 1.2 | 81.5 ± 1.2 | 81.4 ± 1.3 | 1 |
| 9 | hydrogen | hydrogen | 81.1 ± 2.1 | 85.5 ± 1.7 | 99.8 ± 1.7 | 108.8 ± 1.1 | 1.1 |
| 10 | chloro | hydrogen | 38.6 ± 1.6 | 89.1 ± 1.7 | 79.1 ± 1.3 | 172.1 ± 1.4 | 2.2 |
| 11 | methoxy | hydrogen | 237.8 ± 1.7 | 83.8 ± 1.5 | 114.3 ± 1.3 | 81.1 ± 1.4 | 0 |
| 12 | methyl | hydrogen | 79.5 ± 1.8 | 44.6 ± 1.9 | 81.0 ± 1.6 | 106.3 ± 1.4 | 1.3 |
| 13 | hydrogen | 4-methoxyphenyl | 47.5 ± 1.5 | 17.9 ± 2.1 | 76.1 ± 1.6 | 217.8 ± 1.3 | 2.9 |
| 14 | chloro | 4-methoxyphenyl | 26.0 ± 1.4 | 22.5 ± 1.7 | 19.9 ± 1.7 | 109.2 ± 1.2 | 5.5 |
| 15 | methoxy | 4-methoxyphenyl | 39.9 ± 1.6 | 18.1 ± 1.6 | 33.9 ± 1.8 | 118.4 ± 1.4 | 3.5 |
| 16 | methyl | 4-methoxyphenyl | 32.7 ± 1.7 | 21.4 ± 1.7 | 15.7 ± 1.9 | 132.9 ± 1.2 | 8.5 |
| Cisp | NT | 0.017 | 0.017 | 0.017 | |||
*Selectivity index represents the ratio between the IC50 value calculated for the cancerous breast cell line (MDA-MB-231) and the IC50 value calculated for the normal breast cell line (MCF-10a). SH-SY5Y–human neuroblastoma; MDA-MB-231–triple-negative breast cancer; PANC‑1–human pancreatic cancer; and MCF-10a–human mammary cell lines.